top of page
News, Events and Updates
Search
Mar 10, 2016
Anavex Announces 2-Year Clinical Extension Study of ANAVEX 2-73 and Presents Phase 2a Dose-Response
Feb 26, 2016
Assessment of ANAVEX 2-73 in a MECP2 Rett Syndrome Mouse Model
Feb 25, 2016
Anavex Presents Precinical Results of ANAVEX 2-73 in Rett Syndrome
Feb 17, 2016
ANAVEX 2-73 Preclinical Data in New Indication to be Presented at ACTRIMS 2016
Feb 11, 2016
Sigma-1 Receptor Agonists Inhibit Oligodendrocyte Cytotoxicity Induced by Molecules
Feb 8, 2016
Anavex Reports Fiscal First Quarter 2016 Financial Results
Feb 2, 2016
Anavex to Present at 18th Annual BIO CEO & Investor Conference on February 9th 2016
Feb 1, 2016
14th International Athens / Springfield Symposium on Advances in Alzheimer Therapy
Jan 15, 2016
2016 Epilepsy Pipeline Conference
Jan 14, 2016
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2016
Jan 12, 2016
18th Annual CIO CEO & Investor Conference
28
29
30
31
32
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
